Literature DB >> 20401387

Conformational ensembles of flexible beta-turn mimetics in DMSO-d6.

Jari J Koivisto1, Esa T T Kumpulainen, Ari M P Koskinen.   

Abstract

Beta-turns play an important role in peptide and protein chemistry, biophysics, and bioinformatics. The aim of this research was to study short linear peptides that have a high propensity to form beta-turn structures in solution. In particular, we examined conformational ensembles of beta-turn forming peptides with a general sequence CBz-L-Ala-L-Xaa-Gly-L-Ala-OtBu. These tetrapeptides, APGA, A(4R)MePGA, and A(4S)MePGA, incorporate proline, (4R)-methylproline, and (4S)-methylproline, respectively, at the Xaa position. To determine the influence of the 4-methyl substituted prolines on the beta-turn populations, the NAMFIS (NMR analysis of molecular flexibility in solution) deconvolution analysis for these three peptides were performed in DMSO-d(6) solution. The NBO (natural bond orbital) method was employed to gain further insight into the results obtained from the NAMFIS analysis. The emphasis in the NBO analysis was to characterize remote intramolecular interactions that could influence the backbone-backbone interactions contributing to beta-turn stability. NAMFIS results indicate that the enantiospecific incorporation of the methyl substituent at the C(gamma) (C4) position of the proline residue can be used to selectively control the pyrrolidine ring puckering propensities and, consequently, the preferred varphi,psi angles associated with the proline residue in beta-turn forming peptides. The NAMFIS analyses show that the presence of (4S)-methylproline in A(4S)MePGA considerably increased the type II beta-turn population with respect to APGA and A(4R)MePGA. The NBO calculations suggest that this observation can be rationalized based on an n-->pi* interaction between the N-terminus alanine carbonyl oxygen and the proline carbonyl group. Several other interactions between remote orbitals in these peptides provide a more detailed explanation for the observed population distributions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20401387     DOI: 10.1039/b921794k

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  6 in total

1.  8-Triazolylpurines: Towards Fluorescent Inhibitors of the MDM2/p53 Interaction.

Authors:  Mariell Pettersson; David Bliman; Jimmy Jacobsson; Jesper R Nilsson; Jaeki Min; Luigi Iconaru; R Kiplin Guy; Richard W Kriwacki; Joakim Andréasson; Morten Grøtli
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

2.  Halogen Bonding: A Powerful Tool for Modulation of Peptide Conformation.

Authors:  Emma Danelius; Hanna Andersson; Patrik Jarvoll; Kajsa Lood; Jürgen Gräfenstein; Máté Erdélyi
Journal:  Biochemistry       Date:  2017-06-12       Impact factor: 3.162

3.  Assessing the Ability of Spectroscopic Methods to Determine the Difference in the Folding Propensities of Highly Similar β-Hairpins.

Authors:  Hanna Andersson; Emma Danelius; Patrik Jarvoll; Stephan Niebling; Ashley J Hughes; Sebastian Westenhoff; Ulrika Brath; Máté Erdélyi
Journal:  ACS Omega       Date:  2017-02-13

4.  A Chemical Biology Approach to Understanding Molecular Recognition of Lipid II by Nisin(1-12): Synthesis and NMR Ensemble Analysis of Nisin(1-12) and Analogues.

Authors:  Rachael Dickman; Emma Danelius; Serena A Mitchell; D Flemming Hansen; Máté Erdélyi; Alethea B Tabor
Journal:  Chemistry       Date:  2019-10-10       Impact factor: 5.236

5.  Solution Conformations Shed Light on PROTAC Cell Permeability.

Authors:  Yoseph Atilaw; Vasanthanathan Poongavanam; Caroline Svensson Nilsson; Duy Nguyen; Anja Giese; Daniel Meibom; Mate Erdelyi; Jan Kihlberg
Journal:  ACS Med Chem Lett       Date:  2020-12-25       Impact factor: 4.345

6.  Linker-Dependent Folding Rationalizes PROTAC Cell Permeability.

Authors:  Vasanthanathan Poongavanam; Yoseph Atilaw; Stephan Siegel; Anja Giese; Lutz Lehmann; Daniel Meibom; Mate Erdelyi; Jan Kihlberg
Journal:  J Med Chem       Date:  2022-09-28       Impact factor: 8.039

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.